GSK Retained Earnings (Accumulated Deficit) 2010-2024 | GSK

GSK retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $10.648B, a 19.87% increase year-over-year.

  • GSK retained earnings (accumulated deficit) for 2023 were $9.005B, a 66.86% increase from 2022.
  • GSK retained earnings (accumulated deficit) for 2022 were $5.397B, a 50.6% decline from 2021.
  • GSK retained earnings (accumulated deficit) for 2021 were $10.924B, a 25.95% increase from 2020.

GSK Retained Earnings (Accumulated Deficit) 2010-2024 | GSK

  • GSK retained earnings (accumulated deficit) for 2023 were $9.005B, a 66.86% increase from 2022.
  • GSK retained earnings (accumulated deficit) for 2022 were $5.397B, a 50.6% decline from 2021.
  • GSK retained earnings (accumulated deficit) for 2021 were $10.924B, a 25.95% increase from 2020.